Article info
Cancer genetics
An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies
- Correspondence to Dr Maria J Baker, Department of Medicine, Penn State Milton S. Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive CH46, Hershey, PA 17033-0850, USA; mbaker{at}hmc.psu.edu
Citation
An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies
Publication history
- Received August 6, 2015
- Revised November 25, 2015
- Accepted December 22, 2015
- First published January 21, 2016.
Online issue publication
October 21, 2016
Article Versions
- Previous version (21 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/